• Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Sanduphq Share Price

    Sandu Pharmaceuticals Share PriceSandu Pharmaceuticals

    Small Cap 2k Result
    ₹67.05
    -0.98 (-1.44%)
    As on 09 December, 2023 | 00:50 BSE: 524703 NSE: SANDUPHQISIN: INE751D01014

    Sandu Pharmaceuticals Performance

    Day Range

    • Low
    • High
    ₹ 67.05

    52 Week Range

    • Low
    • High
    ₹ 67.05
    • Open Price
    • Previous Close
    • Volume

    Start SIP in Sandu Pharmaceuticals

    Start SIP

    Sandu Pharmaceuticals Share Price

    • Over 1 Month -0.27%
    • Over 3 Month 8.88%
    • Over 6 Month 15.8%
    • Over 1 Year 5.51%

    Sandu Pharmaceuticals Key Statistics

    Sandu Pharmaceuticals Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 17181517171611
    Operating Expenses Qtr Cr 16171516161611
    Operating Profit Qtr Cr 1001101
    Depreciation Qtr Cr 0000000
    Interest Qtr Cr 0000000
    Tax Qtr Cr 0000000
    Net Profit Qtr Cr 1000100
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 6666
    Operating Expenses Annual Cr 6363
    Operating Profit Annual in Cr 23
    Depreciation Cr 11
    Interest Annual Cr 00
    Tax Annual Cr 11
    Net Profit Annual Cr 22
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 01
    Cash from Investing Activity Annual Cr 1-5
    Cash from Financing Annual Activity Cr 11
    Net Cash Flow Annual Cr 1-4
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 3936
    Fixed Assets Annual Cr 1716
    Total Non Current Assets Annual Cr 2926
    Total Current Assets Annual Cr 2624
    Total Assets Annual Cr 5449
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 4141
    ROE Annual % 44
    ROCE Annual % 66
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 45
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 1718151711
    Operating Expenses Qtr Cr 1617151611
    Operating Profit Qtr Cr 10011
    Depreciation Qtr Cr 00000
    Interest Qtr Cr 00000
    Tax Qtr Cr 00000
    Net Profit Qtr Cr 10000
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 66
    Operating Expenses Annual Cr 63
    Operating Profit Annual in Cr 2
    Depreciation Cr 1
    Interest Annual Cr 0
    Tax Annual Cr 1
    Net Profit Annual Cr 2
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 0
    Cash from Investing Activity Annual Cr 1
    Cash from Financing Annual Activity Cr 1
    Net Cash Flow Annual Cr 1
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 39
    Fixed Assets Annual Cr 17
    Total Non Current Assets Annual Cr 29
    Total Current Assets Annual Cr 26
    Total Assets Annual Cr 54
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 41
    ROE Annual % 4
    ROCE Annual % 6
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 4
    Invest in Sandu Pharmaceuticals

    Sandu Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹67.05
    -0.98 (-1.44%)
    pointer
    • Bullish Moving Average
    • ___
    • 7
    • Bearish Moving Average
    • ___
    • 9
    • 20 Day
    • ₹67.50
    • 50 Day
    • ₹66.82
    • 100 Day
    • ₹64.85
    • 200 Day
    • ₹63.02
    • 20 Day
    • ₹68.11
    • 50 Day
    • ₹67.93
    • 100 Day
    • ₹63.71
    • 200 Day
    • ₹60.31

    Sandu Pharmaceuticals Resistance and Support

    PIVOT
    ₹67.3
    Resistance
    First Resistance 67.79
    Second Resistance 68.52
    Third Resistance 69.02
    RSI 48.93
    MFI 72.02
    MACD Single Line 0.24
    MACD 0.16
    Support
    First Resistance 66.56
    Second Resistance 66.06
    Third Resistance 65.33

    Sandu Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 953 81,901 85.94
    Week 4,279 350,091 81.82
    1 Month 6,127 450,117 73.46
    6 Month 9,463 585,106 61.83

    Sandu Pharmaceuticals Result Highlights

    Sandu Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Sandu Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2023-11-13 Quarterly Results
    2023-08-14 Quarterly Results & Final Dividend
    2023-05-30 Audited Results
    2023-02-14 Quarterly Results
    2022-11-14 Quarterly Results

    Sandu Pharmaceuticals FAQs

    What is Share Price of Sandu Pharmaceuticals ?

    Sandu Pharmaceuticals share price is ₹67 As on 09 December, 2023 | 00:36

    What is the Market Cap of Sandu Pharmaceuticals ?

    The Market Cap of Sandu Pharmaceuticals is ₹64.8 Cr As on 09 December, 2023 | 00:36

    What is the P/E ratio of Sandu Pharmaceuticals ?

    The P/E ratio of Sandu Pharmaceuticals is 45.7 As on 09 December, 2023 | 00:36

    What is the PB ratio of Sandu Pharmaceuticals ?

    The PB ratio of Sandu Pharmaceuticals is 1.7 As on 09 December, 2023 | 00:36

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.